Balaji Amines (530999) Aktievy
Balaji Amines Limited är verksamt inom tillverkning och försäljning av metylaminer, etylaminer och derivat av specialkemikalier och farmaceutiska hjälpämnen i Indien. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 1/6 |
| Framtida tillväxt | 4/6 |
| Tidigare resultat | 2/6 |
| Finansiell hälsa | 6/6 |
| Utdelningar | 4/6 |
530999 Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Balaji Amines Limited Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | ₹2,079.00 |
| 52 veckors högsta | ₹2,287.00 |
| 52 veckors lägsta | ₹905.15 |
| Beta | 0.79 |
| 1 månads förändring | 8.27% |
| 3 månaders förändring | 97.18% |
| 1 års förändring | 24.14% |
| 3 års förändring | -10.83% |
| 5 års förändring | -22.04% |
| Förändring sedan börsintroduktionen | 16,485.56% |
Senaste nyheter och uppdateringar
Recent updates
Uppdatering av berättelse • Jun 18
530999: Higher P E And Weaker Margins Will Pressure Future Returns
Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.Uppdatering av berättelse • May 21
530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism
Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Uppdatering av berättelse • May 07
530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside
Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.
Uppdatering av berättelse • Apr 23
530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside
Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.Uppdatering av berättelse • Apr 08
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Uppdatering av berättelse • Mar 24
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.Uppdatering av berättelse • Mar 10
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Uppdatering av berättelse • Feb 23
530999: Higher Future P E And Margins Will Likely Support Returns
Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Uppdatering av berättelse • Feb 09
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Uppdatering av berättelse • Jan 25
530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins
Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Uppdatering av berättelse • Jan 10
530999: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).Uppdatering av berättelse • Dec 25
530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins
Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.Uppdatering av berättelse • Dec 11
530999: Stable Margins And Growth Outlook Will Support Further Upside
Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Uppdatering av berättelse • Nov 27
530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales
Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.Uppdatering av berättelse • Sep 05
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
Ny berättelse • Feb 02
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.Aktieägarnas avkastning
| 530999 | IN Chemicals | IN Marknad | |
|---|---|---|---|
| 7D | -3.5% | 0.3% | 0.3% |
| 1Y | 24.1% | -3.3% | -0.7% |
Avkastning vs industri: 530999 översteg Indian Chemicals branschen som gav -3.3 % under det senaste året.
Avkastning vs Marknaden: 530999 översteg Indian marknaden som gav -0.7 % under det senaste året.
Prisvolatilitet
| 530999 volatility | |
|---|---|
| 530999 Average Weekly Movement | 10.2% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.5% |
Stabil aktiekurs: 530999 s aktiekurs har varit volatil under de senaste 3 månaderna jämfört med marknaden för Indian.
Volatilitet över tid: 530999 s veckovolatilitet ( 10% ) har varit stabil under det senaste året, men är fortfarande högre än 75 % av Indian aktier.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1988 | 1,161 | Dundurapu Reddy | www.balajiamines.com |
Balaji Amines Limited är verksamt inom tillverkning och försäljning av metylaminer, etylaminer och derivat av specialkemikalier och farmaceutiska hjälpämnen i Indien. Företaget är verksamt inom två segment, Chemicals och Hotel. Företaget erbjuder monometylamin, dimetylamin, trimetylamin, monoetylamin, dietylamin, trietylamin samt dimetyl- och dietylaminoetanol; och specialkemikalier, inklusive N-metylpyrrolidon, morfolin, 2-pyrrolidon, N-etyl-2-pyrrolidon, gamma-butyrolakton, dimetylformamid, acetonitril, dimetylkarbonat, propylenglykol och propylenkarbonat.
Balaji Amines Limited Sammanfattning av grunderna
| 530999 grundläggande statistik | |
|---|---|
| Börsvärde | ₹66.97b |
| Vinst(TTM) | ₹1.67b |
| Intäkter(TTM) | ₹14.25b |
40.3x
P/E-förhållande4.7x
P/S-förhållandeÄr 530999 övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| 530999 resultaträkning (TTM) | |
|---|---|
| Intäkter | ₹14.25b |
| Kostnad för intäkter | ₹8.03b |
| Bruttovinst | ₹6.22b |
| Övriga kostnader | ₹4.54b |
| Intäkter | ₹1.67b |
Senast redovisade vinst
Mar 31, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 51.60 |
| Bruttomarginal | 43.62% |
| Nettovinstmarginal | 11.73% |
| Skuld/egenkapitalförhållande | 6.2% |
Hur har 530999 utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
0.5%
Aktuell utdelningsavkastning21%
UtbetalningskvotGer 530999 en tillförlitlig utdelning?
Se 530999 utdelningshistorik och jämförelsetal| Balaji Amines datum för utdelning | |
|---|---|
| Ex utdelningsdag | Jul 03 2026 |
| Utbetalningsdag för utdelning | Aug 09 2026 |
| Dagar till Ex-utdelning | 8 days |
| Dagar till utdelningsdag | 45 days |
Ger 530999 en tillförlitlig utdelning?
Se 530999 utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/24 10:11 |
| Aktiekurs vid dagens slut | 2026/06/24 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2026/03/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Balaji Amines Limited bevakas av 4 analytiker. 1 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Nilesh Ghuge | HDFC Securities Limited |
| Jay Gandhi | HDFC Securities Limited |
| Keshav Lahoti | HDFC Securities Limited |